borderline significanceP = 0.05
Pain reduction, assessed by VAS scores, was significantly greater in the PRP group at 3 months (mean difference: −1.33, P < 0.01, I 2 = 38%) with borderline significance at 6 months (mean difference: −0.78, P = 0.05).
Pain reduction, assessed by VAS scores, was significantly greater in the PRP group at 3 months (mean difference: −1.33, P < 0.01, I 2 = 38%) with borderline significance at 6 months (mean difference: −0.78, P = 0.05).